General Information of Drug (ID: DM2CJ4O)

Drug Name
Rebmab-100 Drug Info
Indication
Disease Entry ICD 11 Status REF
Fallopian tube cancer 2C74 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM2CJ4O

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Galactoside 3(4)-L-fucosyltransferase (FUT3) TTUPAD7 FUT3_HUMAN Not Available [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027929)
2 A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma. Gynecol Oncol. 2015 Aug;138(2):272-7.